跳至主要内容
临床试验/NCT05917210
NCT05917210招募中不适用

Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda

Yale University1 个研究点 分布在 1 个国家目标入组 1,920 人开始时间: 2026年3月16日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
1,920
试验地点
1
主要终点
Effectiveness: TB Treatment Success

研究概览

简要总结

This cluster-randomized trial in Uganda will evaluate the effectiveness and implementation of a novel, peer-led TB education and counseling strategy to improve outcomes among persons with tuberculosis (TB) with and without HIV/AIDS and assess the social-behavioral mechanisms underlying the observed treatment effects.

详细描述

Study Design

Aim 1. The investigators will conduct a parallel, cluster-randomized, hybrid Type 2, effectiveness-implementation trial at 16 sites in Uganda.

This clinical trials registration focuses on Aim 1.

In addition, we will pursue two additional non-interventional aims to better understand the implementation and outcomes of Aim 1:

Aim 2. Within the Aim 1 study, the investigators will also perform a mediation analysis of social and behavioral factors (i.e., TB knowledge, perceived social support, general self-efficacy, HIV/TB stigma) to identify causal mechanisms of impact.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥18 years
  • Registered as a new, relapse, treatment failure, or previously lost-to-follow-up
  • TB case according to the on-site NTP TB Treatment Register
  • Screened and invited to participate within 30 days of TB treatment initiation

排除标准

  • Diagnosed with possible or confirmed drug-resistant TB
  • Transferring TB care into the clinic from an off-site facility
  • Residing >40 km from the enrolling clinic
  • Lacking mental capacity to provide informed consent

结局指标

主要结局

Effectiveness: TB Treatment Success

时间窗: Up to 12 months after TB treatment initiation

Defined according to criteria from the World Health Organization as either: 1. Treatment completion - completion of TB treatment without evidence of treatment failure as documented in the on-site TB treatment register; or 2. Cure - among participants with microbiologically confirmed TB, a negative smear or culture result in the final month of treatment and on at least one previous occasion. The outcome will be assessed as the proportion of participants achieving TB treatment success based on program treatment records.

Effectiveness: Antiretroviral Therapy (ART) Retention

时间窗: At month 6 after ART initiation (+/- 30 days)

Among participants living with HIV and initiated on antiretroviral therapy (ART), ART retention will be defined as being (1) alive and (2) receiving ART, as evidenced by a documented ART medication pickup or documented ART supply at a clinical visit recorded in the on-site ART register or on the ART treatment card. The outcome will be assessed as the proportion of participants living with HIV who are alive and receiving ART at 6 months after ART initiation.

次要结局

  • Implementation: TB Medication Adherence(At month 5 after TB treatment initiation, ±30 days)
  • Implementation: ART Adherence(At month 5 after TB treatment initiation, ±30 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验